The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are ...

The Trump administration's decision to halt a $258 million HIV vaccine research program has sparked widespread concern. This ...

Data from both studies showcased the superiority of twice-yearly injectable, lenacapavir, compared to once-daily oral Truvada and background HIV incidence rates, prompting Gilead to unblind the ...